Hypogonadotropic Hypogonadism
📧 Sign up to get email alerts when something new happens for Hypogonadotropic Hypogonadism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: LutrePulse Hypogonadotropic Hypogonadism [Phase 3]
Phase 3 clinical trial update for LutrePulse addressing hypogonadotropic hypogonadism presenting as primary amenorrhea; study completed with…
-
FDA approval · 2020-12-31FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for GONAL-F (Follitropin alfa) submitted by EMD Serono, Inc.
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of BGS649 in male obese subjects with hypogonadotropic hypogonadism has completed with …
-
CLINICAL_TRIALS trial_result · 2019-10-04Clinical Trial Update: Hypogonadism in Young Men With Type 2 Diabetes [Phase 2]
Phase 2 trial investigating hypogonadism in men with type 2 diabetes; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: Effect of Intranasal Insulin on LH Concentrations in Man [Phase 1, Phase 2]
A clinical trial assessing the effect of intranasal insulin on luteinizing hormone concentrations in humans with hypogonadotropic hypogonadi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-07-12Clinical Trial Update: Pulsatile GnRH in Anovulatory Infertility [Phase 2]
Phase 2 trial update evaluating pulsatile gonadotropin-releasing hormone therapy for anovulatory infertility due to hypogonadotropic hypogon…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH) [Phase 1]
Phase 1 study assessing how different testosterone levels influence insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic Hypogonadism [Phase 2]
TAK-448 was evaluated in a Phase 2a pharmacodynamic study for Hypogonadotropic Hypogonadism, but the trial was terminated and results were p…
-
FDA approval · 2016-12-15FDA Approved: FOLLISTIM AQ — Supplemental Application (Organon LLC)
FDA approved a supplemental application for FOLLISTIM AQ (follitropin) from Organon LLC.
-
CLINICAL_TRIALS research · 2016-08-18Clinical Trial Update: Pubertal Induction in Individuals With Hypogonadism
Clinical trial update describing ongoing research on pubertal induction strategies for individuals with hypogonadism, including related cond…
-
CLINICAL_TRIALS trial_result · 2016-05-09Clinical Trial Update: A Study of the Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adult Men With Hypogonadotropic Hypogonadism (HH) (P07937) [Phase 3]
Phase 3 trial evaluating corifollitropin alfa in combination with hCG for adult men with hypogonadotropic hypogonadism; the study is complet…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome [NA]
This clinical trial update assesses the efficacy of pulsatile GnRH therapy in male patients with Pituitary stalk interruption syndrome; the …
-
FDA approval · 2015-11-19FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)
FDA approved a supplemental application for GONAL-F (follitropin alfa) from EMD Serono, Inc. This approval may involve labeling or indicatio…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism [Phase 4]
Phase 4 clinical trial update comparing two induction-of-ovulation protocols to assess ART outcomes in patients with hypogonadotropic hypogo…
-
FDA approval · 2015-02-09FDA Approved: GONAL-F — Supplemental Application (EMD Serono, Inc.)
The FDA approved a supplemental application for GONAL-F (follitropin alfa) submitted by EMD Serono, Inc.
-
FDA approval · 2015-01-20FDA Approved: MENOPUR — Supplemental Application (Ferring Pharmaceuticals Inc.)
FDA approved a supplemental application for MENOPUR (menotropins) submitted by Ferring Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: Follow-up of Serum Androgen Profile After Bariatric Surgery in Men With Obesity Related Hypogonadotropic Hypogonadism
This entry notes a completed clinical trial investigating the effect of bariatric surgery on serum androgen levels in men with obesity-relat…
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% [Phase 3]
This clinical trial update notes a Phase III randomized, double-blind, placebo-controlled, multicenter study in men with acquired hypogonado…
-
CLINICAL_TRIALS trial_result · 2014-10-01Clinical Trial Update: A Randomized, Double Blind, Placebo-Controlled, Multi-Center Phase III Study in Men With Acquired Hypogonadotropic Hypogonadism to Compare Changes in Testosterone and Sperm Concentration Following Treatment With 12.5 mg or 25 mg Androxal or AndroGel 1.62% [Phase 3]
Phase III randomized, double-blind, placebo-controlled study in men with acquired hypogonadotropic hypogonadism comparing 12.5 mg or 25 mg e…
-
CLINICAL_TRIALS research · 2014-08-04Clinical Trial Update: Baselines in Reproductive Disorders [NA]
This clinical trial update from Massachusetts General Hospital outlines baseline characteristics for a study on reproductive disorders. It l…
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions [Phase 3]
A Phase 3 bioequivalence study comparing test and reference testosterone topical gel 1.62% in hypogonadal men has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Endothelial Dysfunction, Inflammation and Insulin Resistance in Congenital Hypogonadism and Effect of Testosteron Replacement Therapy [Phase 4]
Phase 4 clinical trial evaluating the effects of testosterone replacement therapy on endothelial dysfunction, inflammation and insulin resis…
-
CLINICAL_TRIALS trial_result · 2014-02-13Clinical Trial Update: Bone Mineral Markers in Hypogonadism
Completed clinical trial assessing bone mineral markers in patients with hypogonadotropic hypogonadism, including endothelial dysfunction an…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Sequential Therapy for Hypogonadotropic Hypogonadism [Phase 4]
Phase 4 clinical trial evaluating sequential therapy for hypogonadotropic hypogonadism and Kallmann syndrome has completed. The snippet does…
-
FDA approval · 2014-01-29FDA Approved: CHORIONIC GONADOTROPIN — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for CHORIONIC GONADOTROPIN from Fresenius Kabi USA, LLC.